Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Waks

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|June 5, 2016
Antiarrhythmic Drug Therapy for Rhythm Control in Atrial FibrillationJonathan W Waks, Peter Zimetbaum
Annals of Internal Medicine|June 30, 2025
The Significant Benefits of Ablation for Rhythm Control of Atrial FibrillationJonathan W Waks, Peter Zimetbaum
Journal of the American College of Cardiology|June 20, 2015
Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?Jonathan W Waks, Warren J Manning
Arrhythmia & Electrophysiology Review|February 3, 2016
Mechanisms of Atrial Fibrillation - Reentry, Rotors and RealityJonathan W Waks, Mark E Josephson
Computer Methods and Programs in Biomedicine|September 21, 2023
BRAVEHEART: Open-source software for automated electrocardiographic and vectorcardiographic analysisHans Friedrich Stabenau, Jonathan W Waks
The Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Risk Stratification of Sudden Cardiac Death After Acute Myocardial InfarctionAn H Bui, Jonathan W Waks
Annual Review of Medicine|February 8, 2018
Risk Stratification for Sudden Cardiac Death After Myocardial InfarctionJonathan W Waks, Alfred E Buxton
Journal of Electrocardiology|August 20, 2016
Global electrical heterogeneity: A review of the spatial ventricular gradientJonathan W Waks, Larisa G Tereshchenko
Future Cardiology|July 30, 2011
Established and novel biomarkers in ST-elevation myocardial infarctionJonathan W Waks, Benjamin M Scirica
Expert Review of Cardiovascular Therapy|October 24, 2013
Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentaryJonathan W Waks, Peter J Zimetbaum
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Pharmacology and Therapeutics|June 5, 2016
Antiarrhythmic Drug Therapy for Rhythm Control in Atrial FibrillationJonathan W Waks, Peter Zimetbaum
Annals of Internal Medicine|June 30, 2025
The Significant Benefits of Ablation for Rhythm Control of Atrial FibrillationJonathan W Waks, Peter Zimetbaum
Journal of the American College of Cardiology|June 20, 2015
Left Atrial Appendage Closure to Reduce the Risk of Thromboembolic Complications in Atrial Fibrillation: Pay Now and Possibly Pay Later?Jonathan W Waks, Warren J Manning
Arrhythmia & Electrophysiology Review|February 3, 2016
Mechanisms of Atrial Fibrillation - Reentry, Rotors and RealityJonathan W Waks, Mark E Josephson
Computer Methods and Programs in Biomedicine|September 21, 2023
BRAVEHEART: Open-source software for automated electrocardiographic and vectorcardiographic analysisHans Friedrich Stabenau, Jonathan W Waks
The Journal of Innovations in Cardiac Rhythm Management|June 2, 2020
Risk Stratification of Sudden Cardiac Death After Acute Myocardial InfarctionAn H Bui, Jonathan W Waks
Annual Review of Medicine|February 8, 2018
Risk Stratification for Sudden Cardiac Death After Myocardial InfarctionJonathan W Waks, Alfred E Buxton
Journal of Electrocardiology|August 20, 2016
Global electrical heterogeneity: A review of the spatial ventricular gradientJonathan W Waks, Larisa G Tereshchenko
Future Cardiology|July 30, 2011
Established and novel biomarkers in ST-elevation myocardial infarctionJonathan W Waks, Benjamin M Scirica
Expert Review of Cardiovascular Therapy|October 24, 2013
Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentaryJonathan W Waks, Peter J Zimetbaum
Pageof 11